Quick Answer
Entera Bio Ltd. reported Diluted EPS of $0.25 per share for fiscal year 2025.
Entera Bio Ltd. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.25 | +0.0% |
| 2024 | $0.25 | -19.4% |
| 2023 | $0.31 | -31.1% |
| 2022 | $0.45 | -4.3% |
| 2021 | $0.47 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.07 | -12.5% | +16.7% |
| June 30, 2025 | $0.06 | +0.0% | +0.0% |
| March 31, 2025 | $0.06 | +20.0% | -25.0% |
| September 30, 2024 | $0.08 | +0.0% | +33.3% |
| June 30, 2024 | $0.06 | -25.0% | +20.0% |
| March 31, 2024 | $0.05 | -37.5% | -37.5% |
| September 30, 2023 | $0.08 | -27.3% | +0.0% |
| June 30, 2023 | $0.08 | -27.3% | +0.0% |
- Entera Bio Ltd. showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, Entera Bio Ltd.’s diluted eps has declined by 46.8% (from $0.47 per share to $0.25 per share).
- The most recent figure is from Entera Bio Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: